Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1Phase 2/3 1

Status

Completed 4

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 1Endocrine 1

Conditions

Wounds and Injuries 1Surgical Wound Infection 1Surgical Wound 1Polyps 1Multiple Endocrine Neoplasia Type 1 1Eyelid Diseases 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 641Bevacizumab 552Paclitaxel 534Carboplatin 533Cisplatin 480pembrolizumab 456Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 373Dexamethasone 351Doxorubicin 330Nivolumab 308Fluorouracil 286Capecitabine 260Etoposide 245Prednisone 244Oxaliplatin 242Erlotinib Hydrochloride 242Cytarabine 233Lenalidomide 232Trastuzumab 226Pemetrexed 220Vincristine 212fludarabine phosphate 208Leucovorin 208Cetuximab 208Filgrastim 204Bortezomib 193Methotrexate 183

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Has results × Erythromycin × Clear all
NCT03199911 2020-07-21

Topical Antibiotic Prophylaxis for Eyelids

University of California, San Francisco

Phase 4 Completed
401 enrolled 28 charts

Surgical Wound, Eyelid Diseases, Surgical Wound Infection, Wounds and Injuries

NCT02481219 2017-03-07

Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure

Medtronic - MITG

Phase NA Completed
122 enrolled 10 charts

Polyps

NCT01379183 2016-03-21

Using Magnetic Resonance (MR) to Understand the Effect of Erythromycin on Bowel Motility

Mayo Clinic

Phase 2/3 Completed
40 enrolled 10 charts
Endocrine

Multiple Endocrine Neoplasia Type 1

NCT00718315 2015-01-15

A Study of Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash.

Hoffmann-La Roche

Phase 3 Completed
201 enrolled 16 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡